Literature DB >> 25286085

Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction.

Ji-Yoen Kim1, Stacy D Grunke1, Yona Levites2, Todd E Golde2, Joanna L Jankowsky3.   

Abstract

With the pace of scientific advancement accelerating rapidly, new methods are needed for experimental neuroscience to quickly and easily manipulate gene expression in the mouse brain. Here we describe a technique first introduced by Passini and Wolfe for direct intracranial delivery of virally-encoded transgenes into the neonatal mouse brain. In its most basic form, the procedure requires only an ice bucket and a microliter syringe. However, the protocol can also be adapted for use with stereotaxic frames to improve consistency for researchers new to the technique. The method relies on the ability of adeno-associated virus (AAV) to move freely from the cerebral ventricles into the brain parenchyma while the ependymal lining is still immature during the first 12-24 hr after birth. Intraventricular injection of AAV at this age results in widespread transduction of neurons throughout the brain. Expression begins within days of injection and persists for the lifetime of the animal. Viral titer can be adjusted to control the density of transduced neurons, while co-expression of a fluorescent protein provides a vital label of transduced cells. With the rising availability of viral core facilities to provide both off-the-shelf, pre-packaged reagents and custom viral preparation, this approach offers a timely method for manipulating gene expression in the mouse brain that is fast, easy, and far less expensive than traditional germline engineering.

Entities:  

Mesh:

Year:  2014        PMID: 25286085      PMCID: PMC4199253          DOI: 10.3791/51863

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  11 in total

Review 1.  Neural induction of the blood-brain barrier: still an enigma.

Authors:  H C Bauer; H Bauer
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

2.  Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector.

Authors:  M A Passini; J H Wolfe
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Manipulation of gene expression in the central nervous system with lentiviral vectors.

Authors:  Binggui Sun; Li Gan
Journal:  Methods Mol Biol       Date:  2011

4.  Development of formulations that enhance physical stability of viral vectors for gene therapy.

Authors:  M A Croyle; X Cheng; J M Wilson
Journal:  Gene Ther       Date:  2001-09       Impact factor: 5.250

Review 5.  In vivo electroporation of the central nervous system: a non-viral approach for targeted gene delivery.

Authors:  Jochen De Vry; Pilar Martínez-Martínez; Mario Losen; Yasin Temel; Thomas Steckler; Harry W M Steinbusch; Marc H De Baets; Jos Prickaerts
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

6.  Viral transduction of the neonatal brain delivers controllable genetic mosaicism for visualising and manipulating neuronal circuits in vivo.

Authors:  Ji-Yoen Kim; Ryan T Ash; Carolina Ceballos-Diaz; Yona Levites; Todd E Golde; Stelios M Smirnakis; Joanna L Jankowsky
Journal:  Eur J Neurosci       Date:  2013-01-24       Impact factor: 3.386

7.  In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.

Authors:  Dirk Grimm; Joyce S Lee; Lora Wang; Tushar Desai; Bassel Akache; Theresa A Storm; Mark A Kay
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

8.  Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice.

Authors:  Marco A Passini; Deborah J Watson; Charles H Vite; Daniel J Landsburg; Alyson L Feigenbaum; John H Wolfe
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Gene transfer into rat brain using adenoviral vectors.

Authors:  Mariana Puntel; Kurt M Kroeger; Nicholas S R Sanderson; Clare E Thomas; Maria G Castro; Pedro R Lowenstein
Journal:  Curr Protoc Neurosci       Date:  2010-01

10.  Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain.

Authors:  Paramita Chakrabarty; Awilda Rosario; Pedro Cruz; Zoe Siemienski; Carolina Ceballos-Diaz; Keith Crosby; Karen Jansen; David R Borchelt; Ji-Yoen Kim; Joanna L Jankowsky; Todd E Golde; Yona Levites
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

View more
  62 in total

Review 1.  Viral vectors for therapy of neurologic diseases.

Authors:  Sourav R Choudhury; Eloise Hudry; Casey A Maguire; Miguel Sena-Esteves; Xandra O Breakefield; Paola Grandi
Journal:  Neuropharmacology       Date:  2016-02-21       Impact factor: 5.250

2.  In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation.

Authors:  Hsin-Kai Liao; Fumiyuki Hatanaka; Toshikazu Araoka; Pradeep Reddy; Min-Zu Wu; Yinghui Sui; Takayoshi Yamauchi; Masahiro Sakurai; David D O'Keefe; Estrella Núñez-Delicado; Pedro Guillen; Josep M Campistol; Cheng-Jang Wu; Li-Fan Lu; Concepcion Rodriguez Esteban; Juan Carlos Izpisua Belmonte
Journal:  Cell       Date:  2017-12-07       Impact factor: 41.582

3.  Organ of Corti size is governed by Yap/Tead-mediated progenitor self-renewal.

Authors:  Ksenia Gnedeva; Xizi Wang; Melissa M McGovern; Matthew Barton; Litao Tao; Talon Trecek; Tanner O Monroe; Juan Llamas; Welly Makmura; James F Martin; Andrew K Groves; Mark Warchol; Neil Segil
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-01       Impact factor: 11.205

4.  Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease.

Authors:  Claudia H Huichalaf; Ismael Al-Ramahi; Kyung-Won Park; Stacy D Grunke; Nan Lu; Maria de Haro; Karla El-Zein; Tatiana Gallego-Flores; Alma M Perez; Sung Yun Jung; Juan Botas; Huda Y Zoghbi; Joanna L Jankowsky
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

5.  Neuronal overexpression of human VAPB slows motor impairment and neuromuscular denervation in a mouse model of ALS.

Authors:  Ji-Yoen Kim; Ava Jang; Rohit Reddy; Wan Hee Yoon; Joanna L Jankowsky
Journal:  Hum Mol Genet       Date:  2016-11-01       Impact factor: 6.150

6.  Clptm1 Limits Forward Trafficking of GABAA Receptors to Scale Inhibitory Synaptic Strength.

Authors:  Yuan Ge; Yunhee Kang; Robert M Cassidy; Kyung-Mee Moon; Renate Lewis; Rachel O L Wong; Leonard J Foster; Ann Marie Craig
Journal:  Neuron       Date:  2018-01-25       Impact factor: 17.173

7.  Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain.

Authors:  Hideya Kawasaki; Isao Kosugi; Makiko Sakao-Suzuki; Shiori Meguro; Yoshihiro Tsutsui; Toshihide Iwashita
Journal:  J Vis Exp       Date:  2016-07-24       Impact factor: 1.355

8.  Amyloid precursor protein is a restriction factor that protects against Zika virus infection in mammalian brains.

Authors:  Amy Lingel; Haishuang Lin; Yuval Gavriel; Eric Weaver; Pascal Polepole; Virginia Lopez; Yuguo Lei; Thomas M Petro; Beka Solomon; Chi Zhang; Luwen Zhang
Journal:  J Biol Chem       Date:  2020-10-07       Impact factor: 5.157

9.  An RNA interference screen identifies druggable regulators of MeCP2 stability.

Authors:  Laura M Lombardi; Manar Zaghlula; Yehezkel Sztainberg; Steven A Baker; Tiemo J Klisch; Amy A Tang; Eric J Huang; Huda Y Zoghbi
Journal:  Sci Transl Med       Date:  2017-08-23       Impact factor: 17.956

10.  Late neuroprogenitors contribute to normal retinal vascular development in a Hif2a-dependent manner.

Authors:  Enrico Cristante; Sidath E Liyanage; Robert D Sampson; Aikaterini Kalargyrou; Giulia De Rossi; Matteo Rizzi; Justin Hoke; Joana Ribeiro; Ryea N Maswood; Yanai Duran; Takaaki Matsuki; Nozie D Aghaizu; Ulrich F Luhmann; Alexander J Smith; Robin R Ali; James W B Bainbridge
Journal:  Development       Date:  2018-04-25       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.